Lineage Cell Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:LCTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
26 Nov 24	BuyUS$9,000	George Samuel	Individual	15,000	US$0.60
26 Nov 24	BuyUS$8,850	Jill Howe	Individual	15,000	US$0.59
22 Nov 24	BuyUS$22,640	Michael Mulroy	Individual	40,000	US$0.57
21 Nov 24	BuyUS$24,000	Brian Culley	Individual	40,000	US$0.60
16 Aug 24	BuyUS$9,345	Jill Howe	Individual	10,500	US$0.89
24 May 24	BuyUS$10,500	Brian Culley	Individual	10,000	US$1.05
08 Feb 24	BuyUS$100,001	Don Bailey	Individual	96,155	US$1.04
06 Feb 24	BuyUS$7,000,001	Broadwood Capital, Inc.	Company	6,730,770	US$1.04
29 Dec 23	BuyUS$10,900	Anula Jayasuriya	Individual	10,000	US$1.09

Insider Trading Volume

Insider Buying: LCTX insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LCTX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	943,298	0.428%
Hedge Funds	41,666,255	18.9%
Institutions	54,175,776	24.6%
General Public	123,630,997	56.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26%.

Top Shareholders

Top 25 shareholders own 41.82% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.9%	Broadwood Capital, Inc.	41,666,255	US$20.9m	0%	1.54%
4.5%	BlackRock, Inc.	9,919,800	US$5.0m	3.77%	no data
3.9%	The Vanguard Group, Inc.	8,600,995	US$4.3m	1.5%	no data
2.27%	Defender Capital LLC	5,002,198	US$2.5m	0.59%	0.77%
2.27%	Logos Global Management, L.P.	5,000,000	US$2.5m	6.38%	0.3%
2.05%	Raffles Associates, L.P.	4,507,781	US$2.3m	3.44%	2.31%
1.67%	Geode Capital Management, LLC	3,679,280	US$1.8m	2.32%	no data
1.18%	State Street Global Advisors, Inc.	2,608,352	US$1.3m	1.77%	no data
0.76%	MAI Capital Management, LLC	1,674,679	US$840.7k	2.19%	0.01%
0.62%	Bank of America Corporation, Asset Management Arm	1,372,387	US$688.9k	0.84%	no data
0.61%	Dafna Capital Management, LLC	1,350,708	US$678.1k	0%	0.17%
0.58%	Northern Trust Global Investments	1,274,573	US$639.8k	6.99%	no data
0.38%	Morgan Stanley, Investment Banking and Brokerage Investments	848,283	US$425.8k	63%	no data
0.34%	Bridgeway Capital Management, LLC	756,766	US$379.9k	11%	0.01%
0.26%	British & American Investment Trust PLC	568,978	US$285.6k	0%	3.36%
0.23%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	515,445	US$258.8k	0%	no data
0.23%	JP Morgan Asset Management	500,227	US$251.1k	-4.26%	no data
0.19%	Charles Schwab Investment Management, Inc.	416,223	US$208.9k	-0.05%	no data
0.18%	Prescott General Partners LLC	386,000	US$193.8k	-37.7%	0.01%
0.15%	BNY Asset Management	337,717	US$169.5k	-22.5%	no data
0.14%	Michael Mulroy	298,555	US$149.9k	15.5%	no data
0.11%	Comerica Bank, Banking Investments	250,000	US$125.5k	0%	no data
0.1%	Goldman Sachs Group, Investment Banking and Securities Investments	227,639	US$114.3k	61.2%	no data
0.098%	Long Focus Capital Management LLC	215,000	US$107.9k	0%	0.01%
0.096%	Barclays PLC Private Banking & Investment Banking Investment	211,300	US$106.1k	311%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 05:38
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lineage Cell Therapeutics, Inc. is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jack Allen	Baird
Mayank Mamtani	B. Riley Securities, Inc.
Gum-Ming Lowe	Craig-Hallum Capital Group LLC